Angle-supported intraocular-lens implantation for the correction of moderate to high myopia

Objectives: This study evaluated the efficacy and safety of an angle-supported phakic intraocular lens (PIOL) for the treatment of moderate to high myopia. Methods: This is a case series of 13 eyes of 8 patients with moderate to high myopia that underwent implantation of an acrylic, angle-supporte...

Full description

Saved in:
Bibliographic Details
Main Authors: Kevin Matthew Serafin B. Panggat, MD, Jesus Francisco, III, MD, Pik Sha Chan, MD, Harvey Siy Uy, MD
Format: Article
Language:English
Published: Philippine Academy of Ophthalmology 2011-06-01
Series:Philippine Journal of Ophthalmology
Subjects:
Online Access:https://paojournal.com/index.php/pjo/article/view/279
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849389466051936256
author Kevin Matthew Serafin B. Panggat, MD
Jesus Francisco, III, MD
Pik Sha Chan, MD
Harvey Siy Uy, MD
author_facet Kevin Matthew Serafin B. Panggat, MD
Jesus Francisco, III, MD
Pik Sha Chan, MD
Harvey Siy Uy, MD
author_sort Kevin Matthew Serafin B. Panggat, MD
collection DOAJ
description Objectives: This study evaluated the efficacy and safety of an angle-supported phakic intraocular lens (PIOL) for the treatment of moderate to high myopia. Methods: This is a case series of 13 eyes of 8 patients with moderate to high myopia that underwent implantation of an acrylic, angle-supported PIOL. The main outcome measures were manifest refraction, uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), endothelial-cell count (ECC), intraocular pressure (IOP), and adverse events. Results: The mean spherical equivalent (SE) improved from –11.79 ± 4.12 diopters (D) preoperatively to –0.08 ± 0.58 D postoperatively (p = 0.000), UCVA from 0.016 ± 0.015 to 0.79 ± 0.29 postoperatively (p = 0.000), and BCVA from 0.76 ± 0.33 to 0.86 ± 0.27 (p = 0.017). The ECC slightly decreased from 3033.57 ± 367.71 cells/mm2 preoperatively to 2947 ± 279.86 cells/mm2 (2.8% loss) postoperatively (p = 0.400). The mean preoperative IOP was 16.36 ± 3.53 mm Hg while the mean three-month postoperative IOP was 15.72 ± 4.15 mm Hg (p = 0.659). Two (15%) eyes experienced transient postoperative IOP rise on the day of the surgery, which resolved by postoperative day 1 using topical timolol maleate. The mean follow-up was 2.54 ± 1.39 months (range, 1 to 5 months). Conclusion: Acrylic angle-supported phakic intraocular lens (PIOL) implantation is an effective and safe method of correcting moderate to high myopia.
format Article
id doaj-art-e23b59e00f4c45cbbca7b73f28d26cf7
institution Kabale University
issn 0031-7659
language English
publishDate 2011-06-01
publisher Philippine Academy of Ophthalmology
record_format Article
series Philippine Journal of Ophthalmology
spelling doaj-art-e23b59e00f4c45cbbca7b73f28d26cf72025-08-20T03:41:57ZengPhilippine Academy of OphthalmologyPhilippine Journal of Ophthalmology0031-76592011-06-013613337279Angle-supported intraocular-lens implantation for the correction of moderate to high myopiaKevin Matthew Serafin B. Panggat, MD0Jesus Francisco, III, MD1Pik Sha Chan, MD2Harvey Siy Uy, MD3Asian Eye Instititute Makati, Philippines; Department of Ophthalmology and Visual Sciences University of the Philippines– Philippine General Hospital Manila, PhilippinesAsian Eye Instititute Makati, PhilippinesAsian Eye Instititute Makati, PhilippinesAsian Eye Instititute Makati, Philippines; Department of Ophthalmology and Visual Sciences University of the Philippines– Philippine General Hospital Manila, PhilippinesObjectives: This study evaluated the efficacy and safety of an angle-supported phakic intraocular lens (PIOL) for the treatment of moderate to high myopia. Methods: This is a case series of 13 eyes of 8 patients with moderate to high myopia that underwent implantation of an acrylic, angle-supported PIOL. The main outcome measures were manifest refraction, uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), endothelial-cell count (ECC), intraocular pressure (IOP), and adverse events. Results: The mean spherical equivalent (SE) improved from –11.79 ± 4.12 diopters (D) preoperatively to –0.08 ± 0.58 D postoperatively (p = 0.000), UCVA from 0.016 ± 0.015 to 0.79 ± 0.29 postoperatively (p = 0.000), and BCVA from 0.76 ± 0.33 to 0.86 ± 0.27 (p = 0.017). The ECC slightly decreased from 3033.57 ± 367.71 cells/mm2 preoperatively to 2947 ± 279.86 cells/mm2 (2.8% loss) postoperatively (p = 0.400). The mean preoperative IOP was 16.36 ± 3.53 mm Hg while the mean three-month postoperative IOP was 15.72 ± 4.15 mm Hg (p = 0.659). Two (15%) eyes experienced transient postoperative IOP rise on the day of the surgery, which resolved by postoperative day 1 using topical timolol maleate. The mean follow-up was 2.54 ± 1.39 months (range, 1 to 5 months). Conclusion: Acrylic angle-supported phakic intraocular lens (PIOL) implantation is an effective and safe method of correcting moderate to high myopia.https://paojournal.com/index.php/pjo/article/view/279angle-supported phakic intraocular lensrefractive surgeryendothelialcell counthigh myopia
spellingShingle Kevin Matthew Serafin B. Panggat, MD
Jesus Francisco, III, MD
Pik Sha Chan, MD
Harvey Siy Uy, MD
Angle-supported intraocular-lens implantation for the correction of moderate to high myopia
Philippine Journal of Ophthalmology
angle-supported phakic intraocular lens
refractive surgery
endothelialcell count
high myopia
title Angle-supported intraocular-lens implantation for the correction of moderate to high myopia
title_full Angle-supported intraocular-lens implantation for the correction of moderate to high myopia
title_fullStr Angle-supported intraocular-lens implantation for the correction of moderate to high myopia
title_full_unstemmed Angle-supported intraocular-lens implantation for the correction of moderate to high myopia
title_short Angle-supported intraocular-lens implantation for the correction of moderate to high myopia
title_sort angle supported intraocular lens implantation for the correction of moderate to high myopia
topic angle-supported phakic intraocular lens
refractive surgery
endothelialcell count
high myopia
url https://paojournal.com/index.php/pjo/article/view/279
work_keys_str_mv AT kevinmatthewserafinbpanggatmd anglesupportedintraocularlensimplantationforthecorrectionofmoderatetohighmyopia
AT jesusfranciscoiiimd anglesupportedintraocularlensimplantationforthecorrectionofmoderatetohighmyopia
AT pikshachanmd anglesupportedintraocularlensimplantationforthecorrectionofmoderatetohighmyopia
AT harveysiyuymd anglesupportedintraocularlensimplantationforthecorrectionofmoderatetohighmyopia